Targeting lipid metabolism for the treatment of Anaplastic Thyroid Carcinoma

Por von Roemeling, Christina A., Copland, John A.
Publicado no Expert Opin Ther Targets (2015)

Preclinical evaluation of the mTOR inhibitor, temsirolimus, in combination with the epothilone B analog, ixabepilone in renal cell carcinoma

Por von Roemeling, Christina A, Marlow, Laura A, Kennedy, William P, Kennedy, Gregory T, Copland, John A, Menefee, Michael E
Publicado em 2013

The combination of an mTORc1/TORc2 inhibitor with lapatinib is synergistic in bladder cancer in vitro()

Por Becker, Marie N., Wu, Kevin J., Marlow, Laura A., Kreinest, Pamela A., vonRoemeling, Christina A., Copland, John A., Williams, Christopher R.
Publicado no Urol Oncol (2013)

Aberrant Lipid Metabolism in Anaplastic Thyroid Carcinoma Reveals Stearoyl CoA Desaturase 1 as a Novel Therapeutic Target

Por von Roemeling, Christina A., Marlow, Laura A., Pinkerton, Anthony B., Crist, Angela, Miller, James, Tun, Han W., Smallridge, Robert C., Copland, John A.
Publicado no J Clin Endocrinol Metab (2015)

Neuronal pentraxin 2 supports clear cell renal cell carcinoma by activating the AMPA-selective glutamate receptor-4

Por von Roemeling, Christina A., Radisky, Derek C., Marlow, Laura A., Cooper, Simon J., Grebe, Stefan K., Anastasiadis, Panagiotis Z., Tun, Han W., Copland, John A.
Publicado em 2014

Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma

Por von Roemeling, Christina A., Marlow, Laura A., Wei, Johnny J., Cooper, Simon J., Caulfield, Thomas R., Wu, Kevin, Tan, Winston W., Tun, Han W., Copland, John A.
Publicado em 2013

Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma

Por Yushi, Qiu, Li, Zhimin, Von Roemeling, Christina A., Doeppler, Heike, Marlow, Laura A., Kim, Betty Y.S., Radisky, Derek C., Storz, Peter, Copland, John A., Tun, Han W.
Publicado no Oncotarget (2016)

Pathway Signature and Cellular Differentiation in Clear Cell Renal Cell Carcinoma

Por Tun, Han W., Marlow, Laura A., von Roemeling, Christina A., Cooper, Simon J., Kreinest, Pamela, Wu, Kevin, Luxon, Bruce A., Sinha, Mala, Anastasiadis, Panos Z., Copland, John A.
Publicado em 2010

Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes

Por Qie, Yaqing, Yuan, Hengfeng, von Roemeling, Christina A., Chen, Yuanxin, Liu, Xiujie, Shih, Kevin D., Knight, Joshua A., Tun, Han W., Wharen, Robert E., Jiang, Wen, Kim, Betty Y.S.
Publicado no Sci Rep (2016)

Corrigendum: Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes

Por Qie, Yaqing, Yuan, Hengfeng, von Roemeling, Christina A., Chen, Yuanxin, Liu, Xiujie, Shih, Kevin D., Knight, Joshua A., Tun, Han W., Wharen, Robert E., Jiang, Wen, Kim, Betty Y. S.
Publicado no Sci Rep (2016)

Re-expression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers

Por Cooper, Simon J., von Roemeling, Christina A., Kang, Kylie H., Marlow, Laura A., Grebe, Stefan K., Menefee, Michael E., Tun, Han W., Colon-Otero, Gerardo, Perez, Edith A., Copland, John A.
Publicado em 2012

Functional genomics identifies novel genes essential for clear cell renal cell carcinoma tumor cell proliferation and migration

Por von Roemeling, Christina A., Marlow, Laura A., Radisky, Derek C., Rohl, Austin, Larsen, Hege E., Wei, Johnny, Sasinowska, Heather, Zhu, Heng, Drake, Richard, Sasinowski, Maciek, Tun, Han W., Copland, John A.
Publicado em 2014

Foxo3a drives proliferation in anaplastic thyroid carcinoma through transcriptional regulation of cyclin A1: a paradigm shift that impacts current therapeutic strategies

Por Marlow, Laura A., von Roemeling, Christina A., Cooper, Simon J., Zhang, Yilin, Rohl, Stephen D., Arora, Shilpi, Gonzales, Irma M., Azorsa, David O., Reddi, Honey V., Tun, Han W., Döppler, Heike R., Storz, Peter, Smallridge, Robert C., Copland, John A.
Publicado em 2012